TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER

Patent number:

WO21009029

No items found.

Compounds of formula (I) of the betaxanthin family, or pharmaceutical compositions comprising the same, for use in the treatment and/or prevention of cancer and/or tumours, are described. In addition, the use of nutraceutical compositions, for the prevention of cancer or as chemopreventive compositions, comprising said compounds of formula (I) is described.

Countries:

Spain

Regions:

Region of Murcia

Centers:

UNIVERSIDAD DE MURCIA

Other entities:

Sectors:

Health

Subsectors:

Pharmaceuticals, Organic fine chemistry

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Obtaining larger amounts of betaxanthins compared to other methods used. - Obtaining pure betaxanthins with antitumor properties tested in the C. Elegans animal model.

Comments

Other related patents

Health

Protein kinase inhibitors

Countries

Spain

Health

New peptides to treat cognitive impairment of age-related diseases

Countries

Spain

Health

Chemicals

Aerospace

Automotive & Rail

Textile

PROGRAM METHOD, SYSTEM AND PRODUCT FOR INTERACTION IN VIRTUAL REALITY ENVIRONMENTS THROUGH A HAPTIC DESKTOP FORCES FEEDBACK DEVICE

Countries

Spain

Get back to patents directory